Related Experiment Video
Updated: Jul 6, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Management of massive pulmonary embolism using recombinant activated Factor VII
Guillermo Reyes1, Nieves Carrasco, Teresa Muñoz
1Department of Cardiovascular Surgery, Hospital Universitario La Princesa, c/Diego de León 62, 28006, Madrid, Spain. guillermo_reyes_copa@yahoo.es
Abstract:
Massive pulmonary embolism with concomitant intracranial haemorrhage is a condition associated with high mortality. Emergency embolectomy is indicated in those cases in which medical treatment is not possible. The case of a 65-year-old woman with massive pulmonary embolism after cranial trauma with intracranial haemorrhage and two cardiac arrests prior to surgery is described. The patient suffered a right ventricular failure requiring 6h of extracorporeal circulation. After surgery a bleeding disorder happened despite conventional treatment. The patient was transferred to the ICU with packing. Despite the recent thrombotic event recombinant activated Factor VII (70 microg/kg) was used and the bleeding controlled. No other complications occurred and she was discharged 1 month later. As far as we know this is the first time that recombinant activated Factor VII has been used after a massive pulmonary embolism.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Venous Thrombosis IV: Nursing Management
